News
September 8, 2025
Investor
Notice Regarding Revision of Full-Year Financial Results Forecast for the Fiscal Year Ended July 2025 
September 8, 2025
Investor
Notice Regarding Special Loss (non-consolidated) due to Impairment of Investment in a Subsidiary
September 4, 2025
Investor
Notice Regarding Execution of Loan Agreement with Financial Covenants
August 19, 2025
Investor
Notice Regarding Construction of a New Plant by Our Consolidated Subsidiary and Execution of a Loan Agreement with Financial Covenants
July 16, 2025
Research and Development
Pharma Foods’ Antibody Technology Advances as Takeda Exercises Sequence Purchase Option
June 16, 2025
Investor
Notice Regarding Construction of a New Plant by Our Consolidated Subsidiary and Execution of a Loan Agreement with Financial Covenants
June 10, 2025
Investor
Supplementary Materials of Consolidated Financial Results for the Nine Months Ended April 30, 2025
June 10, 2025
Investor
[Summary]Consolidated Financial Results for the Nine Months Ended April 30, 2025 (Under Japanese GAAP)
May 14, 2025
Investor
Notice Concerning Results of Acquisition of Own Shares Through Off-Auction Own Share Repurchase Trading System (ToSTNeT-3)
May 13, 2025
Investor
Notice Concerning Acquisition of Own Shares and Repurchase of Own Shares Through Off-Auction Own Share Repurchase Trading System (ToSTNeT-3)
September 8, 2025
Investor
Notice Regarding Special Loss (non-consolidated) due to Impairment of Investment in a Subsidiary
September 4, 2025
Investor
Notice Regarding Execution of Loan Agreement with Financial Covenants
August 19, 2025
Investor
Notice Regarding Construction of a New Plant by Our Consolidated Subsidiary and Execution of a Loan Agreement with Financial Covenants
July 16, 2025
Research and Development
Pharma Foods’ Antibody Technology Advances as Takeda Exercises Sequence Purchase Option
June 16, 2025
Investor
Notice Regarding Construction of a New Plant by Our Consolidated Subsidiary and Execution of a Loan Agreement with Financial Covenants
June 10, 2025
Investor
Supplementary Materials of Consolidated Financial Results for the Nine Months Ended April 30, 2025
June 10, 2025
Investor
[Summary]Consolidated Financial Results for the Nine Months Ended April 30, 2025 (Under Japanese GAAP)
May 14, 2025
Investor
Notice Concerning Results of Acquisition of Own Shares Through Off-Auction Own Share Repurchase Trading System (ToSTNeT-3)
May 13, 2025
Investor
Notice Concerning Acquisition of Own Shares and Repurchase of Own Shares Through Off-Auction Own Share Repurchase Trading System (ToSTNeT-3)